Related Experiment Video
Updated: May 21, 2026
05:45
Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
Published on: April 7, 2023
Microencapsulation of probiotics for gastrointestinal delivery
Michael T Cook1, George Tzortzis, Dimitris Charalampopoulos
1Department of Food and Nutritional Sciences, University of Reading, Reading RG6 6AD, UK.
Summary
Microencapsulation protects probiotic bacteria from stomach acid, enhancing their survival and efficacy in the gut. This technology improves the delivery of live bacteria for nutraceutical benefits.
Area of Science:
- Microbiology
- Biotechnology
- Nutraceuticals
Background:
- Probiotic bacteria are widely used as nutraceuticals, with health benefits dependent on gut viability.
- Oral administration leads to significant probiotic loss in the stomach due to acid and bile salts.
- This viability loss reduces the effectiveness of probiotic supplements.
Purpose of the Study:
- To review advancements in microencapsulation of probiotics for improved gastrointestinal survival.
- To identify limitations in current microencapsulation technologies.
- To highlight emerging trends and future research needs in probiotic delivery.
Main Methods:
- Review of scientific literature on probiotic microencapsulation techniques.
- Analysis of polymer matrix-based immobilization for controlled release.
- Comparison with diffusion-based controlled release systems.
Main Results:
- Microencapsulation protects probiotics from harsh gastric conditions.
- Polymer matrices offer a viable strategy for enhanced probiotic delivery.
- Current technologies show promise but require further development.
Conclusions:
- Microencapsulation is a key strategy to improve probiotic efficacy.
- Further research is needed to optimize microencapsulation for controlled intestinal release.
- Advancements in this field hold significant potential for the nutraceutical industry.
Related Concept Videos
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:18Drug Delivery: Enteral Route
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Drugs in...
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...